Literature DB >> 17219137

Effects of MDMA on blood glucose levels and brain glucose metabolism.

M L Soto-Montenegro1, J J Vaquero, C Arango, G Ricaurte, P García-Barreno, M Desco.   

Abstract

PURPOSE: This study was designed to assess changes in glucose metabolism in rats administered single or repeated doses of MDMA.
METHODS: Two different experiments were performed: (1) A single-dose study with four groups receiving 20 mg/kg, 40 mg/kg, saline or heat, and (2) a repeated-dose study with two groups receiving three doses, at intervals of 2 h, of 5 mg/kg or saline. Rats were imaged using a dedicated small-animal PET scanner 1 h after single-dose administration or 7 days after repeated doses. Glucose metabolism was measured in 12 cerebral regions of interest. Rectal temperature and blood glucose were monitored.
RESULTS: Peak body temperature was reached 1 h after MDMA administration. Blood glucose levels decreased significantly after MDMA administration. In the single-dose experiment, brain glucose metabolism showed hyperactivation in cerebellum and hypo-activation in the hippocampus, amygdala and auditory cortex. In the repeated-dose experiment, brain glucose metabolism did not show any significant change at day 7.
CONCLUSION: These results are the first to indicate that MDMA has the potential to produce significant hypoglycaemia. In addition, they show that MDMA alters glucose metabolism in components of the motor, limbic and somatosensory systems acutely but not on a long-term basis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219137     DOI: 10.1007/s00259-006-0262-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  51 in total

1.  Positron emission tomography findings in heavy users of MDMA.

Authors:  J Holland
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

2.  Experiment assessment of mass effects in the rat: implications for small animal PET imaging.

Authors:  E M Jagoda; J J Vaquero; J Seidel; M V Green; W C Eckelman
Journal:  Nucl Med Biol       Date:  2004-08       Impact factor: 2.408

3.  Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat.

Authors:  G Wilkerson; E D London
Journal:  Neuropharmacology       Date:  1989-10       Impact factor: 5.250

4.  Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

Authors:  R Buchert; J Obrocki; R Thomasius; O Väterlein; K Petersen; L Jenicke; K H Bohuslavizki; M Clausen
Journal:  Nucl Med Commun       Date:  2001-08       Impact factor: 1.690

Review 5.  Malignant hyperthermia: biochemical aspects of the acute episode.

Authors:  J J Heffron
Journal:  Br J Anaesth       Date:  1988-02       Impact factor: 9.166

Review 6.  The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

Authors:  S R White; T Obradovic; K M Imel; M J Wheaton
Journal:  Prog Neurobiol       Date:  1996-08       Impact factor: 11.685

Review 7.  Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Authors:  G A Ricaurte; U D McCann; Z Szabo; U Scheffel
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

8.  Bufuralol 1'-hydroxylase activity of the rat. Strain differences and the effects of inhibitors.

Authors:  A R Boobis; C E Seddon; D S Davies
Journal:  Biochem Pharmacol       Date:  1986-09-01       Impact factor: 5.858

9.  Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.

Authors:  J F Nash; B L Roth; J D Brodkin; D E Nichols; G A Gudelsky
Journal:  Neurosci Lett       Date:  1994-08-15       Impact factor: 3.046

10.  The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

Authors:  D M Stone; D C Stahl; G R Hanson; J W Gibb
Journal:  Eur J Pharmacol       Date:  1986-08-22       Impact factor: 4.432

View more
  6 in total

1.  Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain.

Authors:  Rashida Pachmerhiwala; Nirmal Bhide; Megan Straiko; Gary A Gudelsky
Journal:  Eur J Pharmacol       Date:  2010-07-13       Impact factor: 4.432

Review 2.  Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.

Authors:  Gary A Gudelsky; Bryan K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-10-16       Impact factor: 3.533

3.  Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine.

Authors:  Devon L Graham; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams
Journal:  Neurotoxicol Teratol       Date:  2009-09-06       Impact factor: 3.763

4.  The effects of ecstasy on liver function tests, blood glucose, and lipids profile of male rats.

Authors:  Mohammad Reza Shahraki; Mahdieh Irani
Journal:  Int J High Risk Behav Addict       Date:  2014-09-17

5.  Profound hypoglycemia with ecstasy intoxication.

Authors:  Perliveh Carrera; Vivek N Iyer
Journal:  Case Rep Emerg Med       Date:  2015-01-27

6.  Neuroimaging reveals distinct brain glucose metabolism patterns associated with morphine consumption in Lewis and Fischer 344 rat strains.

Authors:  Mª Luisa Soto-Montenegro; Verónica García-Vázquez; Nicolás Lamanna-Rama; Gonzalo López-Montoya; Manuel Desco; Emilio Ambrosio
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.